Kenneth Galbraith, Chair & CEO: Zymeworks ZYME Planned sale · Filed 01/12

Trade details

Type: Planned sale notice
Stock: Zymeworks ZYME
Person: Kenneth GalbraithChair & CEO
Planned sale date: 26/01/12
Filed: 26/01/12

More to sell after $2.6M in 3 months

Zymeworks trades, last 26 weeks

What else happened in Zymeworks around then

Filed or reported within 30 days of the trade day · 25/12/13~02/11

Kenneth Galbraith's recent trades

Kenneth GalbraithChair & CEO
SellZymeworks
Sell
Zymeworks
ZYME
$689.7K
30,424 sh
$689.7K
Filed 01/12
Traded 01/12
Kenneth GalbraithChair & CEO
SellZymeworks
Sell
Zymeworks
ZYME
$795.3K
31,686 sh
$795.3K
Filed 01/05
Traded 01/05
Kenneth GalbraithChair & CEO
SellZymeworks
Sell
Zymeworks
ZYME
$568.7K
22,657 sh
$568.7K
Filed 01/05
Traded 01/05
Kenneth GalbraithChair & CEO
Planned saleZymeworks
Planned sale
Zymeworks
ZYME
$1.4M
54,343 sh
$1.4M
Filed 01/05
Traded 01/05
Kenneth GalbraithChair & CEO
SellZymeworks
Sell
Zymeworks
ZYME
$1.3M
47,528 sh
$1.3M
Filed 25/12/22
Traded 25/12/22

Kenneth Galbraith, Chairman — plans to sell 30,424 sh of Zymeworks ZYME · $704.9K · around 01/12 | Whalegun